Name

Proxis Developpement

Legal name

Proxis Développement

Website

https://proxis-developpement.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Specialty Industrial Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414), Beverage Manufacturing (3121), Food Manufacturing (311)

SIC

Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836), Chemicals & Allied Products (2800)

akta.pro primary industry

Probiotic/Prebiotic Functional Beverage Production (Non-Fermented) (AFAFAFAE)

akta.pro secondary industries

Probiotic & Live-Culture Beverage Production (Shots, Tonics) (AFAFAHAE), Probiotic/Direct-Fed Microbial (DFM) Premixes (AFADAGAG)

Keywords

• Industrial water treatment
• Custom fragrance manufacturing
• Industrial biotechnology fermentation
• Pharmaceutical API manufacturing
• Specialty industrial chemicals

Headquarters

HQ city

Levallois-perret

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Water treatment solutions: Comprehensive water treatment systems and services for industrial and tertiary water cycles, including cooling circuits, boiler circuits, wastewater treatment, serving automotive, energy, petrochemicals, steel, paper, food and beverages sectors
2. Biotechnology products: Probiotics, postbiotics, microbial fertilizers, lactic cultures for dairy industry, dietary supplements, crop nutrition products
3. Fragrance ingredients and products: Customized scent solutions for perfumes, cosmetics, detergents, and industrial applications. Fine fragrance, alcohol-based perfumes, cosmetic scents, detergent fragrances, industrial fragrance blends
4. Pharmaceutical APIs and intermediates: High-potency Active Pharmaceutical Ingredients, GMP intermediates, custom NCE development, generic APIs, complex cytotoxic molecules for anti-cancer treatments

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Proxis Developpement is an independent French family industrial group that manufactures and sells water treatment solutions (Aquaprox), natural and custom fragrances (Sozio), biotechnology products including probiotics, postbiotics, microbial fertilizers and lactic cultures (Bioprox), and high-potency Active Pharmaceutical Ingredients and GMP intermediates (Icrom). It delivers these customized products and solutions primarily through B2B enterprise sales to industrial customers across automotive, energy, petrochemicals, steel, paper, food & beverage, dairy, cosmetics, home care, and pharmaceutical sectors in more than 80 export-driven countries.

Product overview

Proxis Développement is an independent French family industrial group organized into four core business units: AQUAPROX (water treatment solutions for industrial and tertiary sectors), SOZIO (natural and custom fragrances dating back to 1758), BIOPROX (biotechnology and nutrition including probiotics, microbial fertilizers, and lactic cultures), and ICROM (high-potency Active Pharmaceutical Ingredients and GMP intermediates for the pharmaceutical industry). The group also includes several specialized sub-brands under Bioprox: Bioprox Phéromones (INRAe-licensed pheromones), Bioprox Cultures (industrial fermentation), Bioprox Healthcare (probiotic bacteria for dietary supplements), Cybele Agrocare (crop nutrition Ag-tech), and G&GTK (biotech company). The portfolio spans water treatment, fragrances, nutrition/biotechnology, and pharmaceuticals across global markets with 80% export sales.

Differentiator

Problem solved

Functional benefit

Brands

• AQUAPROX: Water treatment solutions for industrial and tertiary sectors, including cooling circuits, boiler circuits, industrial process water, wastewater treatment, and tertiary water systems
• SOZIO
• BIOPROX
• ICROM
• Bioprox Phéromones
• Bioprox Cultures
• Bioprox Healthcare
• Cybele Agrocare
• G&GTK

Products and services

• Aquaprox water treatment solutions Cutting-edge water treatment solutions for industrial and tertiary sectors, covering cooling circuits, boiler circuits, industrial process water, wastewater treatment, and tertiary building water networks for industries such as automotive, energy, petrochemicals, steel, paper, and food & beverage.
• Sozio fragrances Customized fragrance and perfume ingredient solutions combining 260 years of know-how with modern innovation, serving fine fragrance, cosmetics, detergents, and industrial applications with natural and eco-friendly raw materials.
• Bioprox biotechnology and nutrition products

Quantifiable outcome

• 370 M€ annual revenue with 80% from exports across 5 continents
• +2 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• INRAe (French National Research Institute for Agriculture, Food and Environment)coreStrategic or Co-development PartnerBioprox Phéromones operates under INRAe license, marketing quality pheromone products for over 25 years. This partnership provides access to cutting-edge agricultural and environmental research for product development.
• Hospital Institute of MarseillecoreStrategic or Co-development PartnerG&GTK, a science-driven biotech company created in 2013, was incubated at the Hospital Institute of Marseille, indicating a research-oriented partnership for biotech innovation.
• Suppliers, service providers, and subcontractorscoreStrategic or Co-development PartnerProxis extends its commitment to integrity and sustainability throughout its value chain by working with partners including suppliers, service providers, and subcontractors. This approach is a cornerstone of their CSR strategy aimed at creating sustainable value for all stakeholders.
• Global pharmaceutical companiescoreStrategic or Co-development PartnerIcrom works closely with global pharmaceutical companies as a trusted partner for advanced pharmaceutical ingredients, adhering to highest international standards of quality and safety.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ecolab: US-listed global leader in water, hygiene, and infection prevention solutions for industrial and commercial customers. Broadly comparable to Aquaprox's industrial and tertiary water treatment solutions, though at much larger scale and with broader portfolio.
• Symrise: German-listed global supplier of fragrances, flavors, and nutritional ingredients. Comparable to Sozio in fine fragrance and cosmetic scent creation, and to Bioprox in nutritional and probiotic ingredients.
• Givaudan: Swiss global leader in fragrance and flavor creation. Comparable to Sozio as a broader incumbent in fine fragrance, cosmetics, and home care scent creation, though operating at vastly larger scale.
• IFF (International Flavors & Fragrances): US-listed global ingredients powerhouse spanning flavors, fragrances, enzymes, and cultures. Comparable to both Sozio in fragrance creation and Bioprox in fermentation cultures, with broader portfolio scale.

Direct peers

• Lesaffre: French family-owned global fermentation specialist producing yeast, probiotics, and fermentation-derived ingredients for food and agri-food. Direct comparable to Bioprox Cultures' industrial fermentation and lactic cultures for the dairy industry.
• Novonesis (formerly Chr. Hansen): Global market leader in microbial and probiotic solutions for food, supplements, and agriculture. Closely comparable to Bioprox Healthcare's probiotic bacteria production and Bioprox Cultures' industrial fermentation capabilities.
• Robertet: French family-owned global fragrance and flavor house with deep heritage, comparable to Sozio in custom scent creation for fine fragrance, cosmetics, and home care. Similar heritage positioning and family-controlled governance structure.
• Olon: Italian privately-held API manufacturer with strong position in generics, high-potency APIs, and fermentation-derived ingredients. Directly comparable to Icrom in API manufacturing capabilities and to Bioprox in fermentation-based production.
• Siegfried Holding: Swiss-listed CDMO specializing in APIs including high-potency and cytotoxic ingredients for global pharma. Directly comparable to Icrom's API manufacturing franchise in customer base, regulatory profile, and product complexity.
• Lallemand: Canadian privately-held specialist in yeast, bacteria, and fermentation-derived products for baking, nutrition, and agriculture. Direct peer to Bioprox Cultures and Bioprox Healthcare in microbial fermentation and probiotic production.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/proxis-developpement

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proxis Developpement